NEW YORK (GenomeWeb) – Medicare contractor Palmetto GBA yesterday released a number of draft local coverage determinations (LCD) related to comprehensive genomic profiling in specific disease settings without a requirement that labs performing such testing submit patient outcomes data to a registry.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.